Effimune effimune.com


Public lists: Pharma Startups (4733)

Effimune conducts research and development of drug candidates for transplantation and immune-mediated diseases. The Company specializes in the development of first-in-class biological drug candidates targeting cells of the immune system to restore the balance between effector and regulatory mechanisms.

Effimune conducts research and development of drug candidates for transplantation and immune-mediated diseases. The Company specializes in the development of first-in-class biological drug candidates targeting cells of the immune system to restore th...Show all

Company (Merged)

Phone: +33 (0) 2 40 412 834

Fax:

Faculte de Medecine
1 Rue Gaston Veil
Nantes, 44035
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Effimune $0M Feb 24, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Effimune Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-cd28 humanized antibodies Jul 08, 2014 Feb 07, 2017 Patent
Antibodies directed against the alpha chain of il7 receptor—their use for the preparation of drug candidates Oct 04, 2012 Sep 20, 2016 Patent
Anti-cd28 humanized antibodies Feb 16, 2011 Jul 22, 2014 Patent
Monovalent ligands of the human cd28 receptor Oct 08, 2010 Jul 22, 2014 Patent